(Q48617665)

13 February 2018

title

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. (English)

1 reference

13 February 2018

1 reference

H S White

1

1 reference

13 February 2018

S D Brown

2

1 reference

13 February 2018

J H Woodhead

3

1 reference

13 February 2018

G A Skeen

4

1 reference

13 February 2018

H H Wolf

5

1 reference

13 February 2018

publication date

1 October 1997

1 reference

13 February 2018

published in

Epilepsy Research

1 reference

13 February 2018

volume

28

1 reference

13 February 2018

page(s)

167-179

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

A note on a simple apparatus for detecting neurological deficit in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Development and biological applications of chloride-sensitive fluorescent indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2897%2900045-4

7 January 2021

10.1016/S0920-1211(97)00045-4

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9332882

1 reference

13 February 2018